Only Meta Align contains Bifantis® (Bifidobacterium infantis 35624 or B.infantis 35624), a unique, patented, pure-strain probiotic.
Discover the potential health benefits, the proposed mechanisms of action, and the safety of probiotics. Review articles on probiotics, preclinical and clinical data on B.infantis 35624 and other scientific review articles on B.infantis 35624. And, if you're interested in obtaining even more information about probiotics, explore various other professional resources on the topic.
Meta Align – Patented strain demonstrated statistically significant improvement in IBS symptoms^
6 in 10 patients reported significant relief from IBS symptoms after 4 weeks of treatment
Meta Align patients saw 20% improvement in global symptom assessment vs. placebo in symptoms of abdominal discomfort or pain, bloating or distension and altered bowel habit.
^Dose ranging study that investigated the efficacy and safety profile of B.Infantis 35624 in the treatment of subjects with Irritable Bowel Syndrome (IBS). Study included: 2-week run-in; 4-week treatment; 2-week follow-up period. Dosage range: 1X1010 B.Infantis 35624 capsule (1X109-1X1011), 1X108 B. Infantis 35624 capsule (1X107-1X109), 1X106 B.Infantis 35624 capsule (1X105-1X107), placebo (capsule) . Primary endpoint was abdominal pain/discomfort at week 4.
† Data extracted from patients responded ‘yes’ or ‘no’ to the question: Compared to the way you felt before beginning the medication, in particular your general well being and symptoms of abdominal discomfort or pain, bloating or distension and altered bowel habit, have you had adequate relief of your IBS symptoms?
‡ Data extracted from assessed using a 6-point scale where 0=no symptoms and 5=very severe symptoms.